Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C14H29NO4 |
| Molecular Weight | 275.3844 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOCCCCCCN1C[C@H](O)[C@@H](O)[C@@H](O)[C@H]1C
InChI
InChIKey=BBIRATBJZBAXFS-ZOBORPQBSA-N
InChI=1S/C14H29NO4/c1-3-19-9-7-5-4-6-8-15-10-12(16)14(18)13(17)11(15)2/h11-14,16-18H,3-10H2,1-2H3/t11-,12+,13+,14-/m1/s1
| Molecular Formula | C14H29NO4 |
| Molecular Weight | 275.3844 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
UT-231B is an iminosugar that was under development by United Therapeutics Corporation as an oral drug for the treatment of hepatitis C virus (HCV). UT-231B completed acute and chronic Phase I dosing studies in early 2003. A Phase II proof-of-concept study for UT-231B in patients infected with hepatitis C who have failed conventional therapies was started, but the development of drug seemed to be discontinued.
Originator
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:34:37 UTC 2023
by
admin
on
Sat Dec 16 01:34:37 UTC 2023
|
| Record UNII |
MK831RYX9D
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID80186210
Created by
admin on Sat Dec 16 01:34:37 UTC 2023 , Edited by admin on Sat Dec 16 01:34:37 UTC 2023
|
PRIMARY | |||
|
9802484
Created by
admin on Sat Dec 16 01:34:37 UTC 2023 , Edited by admin on Sat Dec 16 01:34:37 UTC 2023
|
PRIMARY | |||
|
324759-98-0
Created by
admin on Sat Dec 16 01:34:37 UTC 2023 , Edited by admin on Sat Dec 16 01:34:37 UTC 2023
|
PRIMARY | |||
|
MK831RYX9D
Created by
admin on Sat Dec 16 01:34:37 UTC 2023 , Edited by admin on Sat Dec 16 01:34:37 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
in vitro studies showed that UT-231B has potent antiviral activity against bovine viral diarrhea virus (BVDV). BVDV has a high degree of homology with HCV
|
